Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.36 |
| ▸ | EGLN3 | Q9H6Z9 | 1/20 | 0.34 |
| ▸ | MAPT | P10636 | 1/20 | 0.34 |
| ▸ | CYP24A1 | Q07973 | 1/20 | 0.34 |
| ▸ | TBXAS1 | P24557 | 5/20 | 0.33 |
| ▸ | FAAH | O00519 | 1/20 | 0.33 |
| ▸ | MGLL | Q99685 | 1/20 | 0.33 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.32 |
| ▸ | HTT | P42858 | 1/20 | 0.32 |
| ▸ | FDPS | P14324 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3027719 | 0.92 | L3MBTL1 (0.38) | L3MBTL1ALDH1A1EGLN3MAPTCYP24A1 | |
| SCHEMBL999664 | 0.88 | L3MBTL1 (0.36) | L3MBTL1ALDH1A1EGLN3MAPTCYP24A1 | |
| SCHEMBL156615 | 0.87 | MAPT (0.37) | L3MBTL1ALDH1A1EGLN3MAPTCYP24A1 | |
| SCHEMBL9610803 | 0.83 | CYP24A1 (0.38) | L3MBTL1ALDH1A1EGLN3MAPTCYP24A1 | |
| SCHEMBL20996818 | 0.83 | MAPT (0.36) | L3MBTL1ALDH1A1EGLN3MAPTCYP24A1 | |
| SCHEMBL22160768 | 0.80 | CYP24A1 (0.37) | L3MBTL1ALDH1A1EGLN3MAPTCYP24A1 | |
| SCHEMBL9612195 | 0.79 | L3MBTL1 (0.42) | L3MBTL1ALDH1A1EGLN3MAPTCYP24A1 | |
| SCHEMBL7033719 | 0.79 | CYP19A1 (0.37) | L3MBTL1ALDH1A1EGLN3MAPTCYP24A1 | |
| SCHEMBL19239719 | 0.79 | ALDH1A1 (0.34) | L3MBTL1ALDH1A1MAPTCYP24A1TBXAS1 | |
| SCHEMBL5314422 | 0.78 | ALDH1A1 (0.36) | ALDH1A1EGLN3MAPTCYP24A1TBXAS1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8476473-B2 | Compound, method for preparing the compound and resist composition containing the compound | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2013-07-02 | — | — | US | disclosed |
| US-8476473-B2 | Compound, method for preparing the compound and resist composition containing the compound | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2013-07-02 | — | — | US | disclosed |
| US-20100055609-A1 | COMPOUND, METHOD FOR PREPARING THE COMPOUND AND RESIST COMPOSITION CONTAINING THE COMPOUND | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2010-03-04 | — | — | US | disclosed |
| US-20100055609-A1 | COMPOUND, METHOD FOR PREPARING THE COMPOUND AND RESIST COMPOSITION CONTAINING THE COMPOUND | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2010-03-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100055609-A1 | COMPOUND, METHOD FOR PREPARING THE COMPOUND AND RESIST COMPOSITION CONTAINING THE COMPOUND | AFF1, H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16, AFF4 | L3MBTL1 2267/4885ALDH1A1 3688/4885EGLN3 1478/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.